Company news

OpSens Inc news in 2022

OpSens Inc's news releases, calls and decks from 2022, newest first.

View company

OpSens announces filing of preliminary base shelf prospectus

December 22, 2022

OpSens announces closing of $11.5 million bought deal public offering including $1.5 million over-allotment option exercised in full

December 22, 2022

OpSens Inc. announces $10 million bought deal offering

December 1, 2022

OpSens announces first SavvyWire(tm) procedure in New Zealand

November 29, 2022

OpSens announces fourth quarter and fiscal year 2022 Financial results

November 22, 2022

OpSens to host fourth quarter fiscal year 2022 financial results conference call and year-end update on November 22, 2022

November 16, 2022

OpSens announces departure of CFO

November 1, 2022

OpSens announces first SavvyWire clinical cases in Europe and launch of SAFE-TAVI study

October 26, 2022

OpSens announces first SavvyWire procedure in the United States by Dr. Philippe Genereux of Morristown Medical Center

September 23, 2022

OpSens announces FDA clearance for the SavvyWire(tm) for use in transcatheter aortic valve replacement (TAVR) procedures

September 15, 2022

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022

September 14, 2022

OpSens announces third quarter fiscal 2022 financial results with record quarterly revenues

July 14, 2022

OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III

July 11, 2022

OpSens to host third quarter fiscal year 2022 financial results conference call on Thursday, July 14

July 7, 2022

OpSens announces global SavvyWire(tm) first commercial use

June 7, 2022

OpSens SavvyWire(tm) first-in-human results presented at europcr in paris and simultaneously published in eurointervention journal

May 19, 2022

OpSens announces publication in jscai of data supporting the correlation between the OptoWire and a novel TAVR interface with standard of care, before and after TAVR

May 18, 2022

OpSens announces Health Canada approval for its new TAVR guidewire

April 26, 2022

OpSens announces second quarter fiscal 2022 Financial results

April 13, 2022

OpSens to host second quarter fiscal year 2022 financial results conference call on Wednesday, April 13

April 6, 2022

OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th to 17th

March 14, 2022

OpSens Reports on Voting Results from its Annual Shareholders Meeting

February 25, 2022

OpSens appoints Brad Davis as new chief commercial officer

February 9, 2022

OpSens announces abiomed 4-year supply agreement extension to 2028

February 1, 2022

OpSens named to 2022 OTCQX Best 50

January 24, 2022

OpSens Announces FIRST Quarter fiscal 2022 Financial Results

January 13, 2022

OpSens to host first quarter fiscal year 2022 financial results conference call on Thursday, January 13, 2022

January 6, 2022

Decks in 2022